Ubiquitin-proteasome system (UPS) as a target for anticancer treatment

被引：272

作者：

Park, Jinyoung ^{[1
]}

Cho, Jinhong ^{[2
]}

Song, Eun Joo ^{[2
]}

机构：

[1] Korea Inst Sci & Technol, Mol Recognit Res Ctr, Hwarangno 14 Gil 5, Seoul 02792, South Korea

[2] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, 52 Ewhayeodae Gil, Seoul 03760, South Korea

来源：

ARCHIVES OF PHARMACAL RESEARCH | 2020年 / 43卷 / 11期

基金：

新加坡国家研究基金会;

关键词：

Ubiquitin– proteasome system (UPS); E3; ligase; Deubiquitinating enzymes (DUBs); Proteasome; Cancer; Small molecule inhibitors; MULTIPLE-MYELOMA CELLS; CANCER THERAPEUTIC TARGET; SMALL-MOLECULE INHIBITOR; TUMOR-SUPPRESSOR CYLD; FATTY-ACID SYNTHASE; NF-KAPPA-B; BREAST-CANCER; IN-VIVO; PROMOTES PROLIFERATION; CYCLIN-E;

D O I：

10.1007/s12272-020-01281-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The ubiquitin-proteasome system (UPS) plays an important role in the cellular processes for protein quality control and homeostasis. Dysregulation of the UPS has been implicated in numerous diseases, including cancer. Indeed, components of UPS are frequently mutated or abnormally expressed in various cancers. Since Bortezomib, a proteasome inhibitor, received FDA approval for the treatment of multiple myeloma and mantle cell lymphoma, increasing numbers of researchers have been seeking drugs targeting the UPS as a cancer therapeutic strategy. Here, we introduce the essential component of UPS, including ubiquitinating enzymes, deubiquitinating enzymes and 26S proteasome, and we summarize their targets and mechanisms that are crucial for tumorigenesis. In addition, we briefly discuss some UPS inhibitors, which are currently in clinical trials as cancer therapeutics.

引用

页码：1144 / 1161

页数：18

共 155 条

[1] Oncogenic Role of the E3 Ubiquitin Ligase NEDD4-1, a PTEN Negative Regulator, in Non-Small-Cell Lung Carcinomas [J].

Amodio, Nicola ;

Scrima, Marianna ;

Palaia, Lucia ;

Salman, Ali Naeem ;

Quintiero, Alfina ;

Franco, Renato ;

Botti, Gerardo ;

Pirozzi, Pino ;

Rocco, Gaetano ;

De Rosa, Nicla ;

Viglietto, Giuseppe .

AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (05) :2622-2634

[2] Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics [J].

Antao, Ainsley Mike ;

Tyagi, Apoorvi ;

Kim, Kye-Seong ;

Ramakrishna, Suresh .

CANCERS, 2020, 12 (06) :1-36

[3] Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events [J].

Arastu-Kapur, Shirin ;

Anderl, Janet L. ;

Kraus, Marianne ;

Parlati, Francesco ;

Shenk, Kevin D. ;

Lee, Susan J. ;

Muchamuel, Tony ;

Bennett, Mark K. ;

Driessen, Christoph ;

Ball, Andrew J. ;

Kirk, Christopher J. .

CLINICAL CANCER RESEARCH, 2011, 17 (09) :2734-2743

[4] Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly [J].

Arendt, CS ;

Hochstrasser, M .

EMBO JOURNAL, 1999, 18 (13) :3575-3585

[5] Skp2 in the ubiquitin-proteasome system: A comprehensive review [J].

Asmamaw, Moges Dessale ;

Liu Ying ;

Zheng Yi-Chao ;

Shi Xiao-Jing ;

Liu Hong-Min .

MEDICINAL RESEARCH REVIEWS, 2020, 40 (05) :1920-1949

[6] Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy [J].

Aubry, Arthur ;

Yu, Tao ;

Bremner, Rod .

CELL DEATH DISCOVERY, 2020, 6 (01)

[7] Assembly, structure, and function of the 26S proteasome [J].

Bedford, Lynn ;

Paine, Simon ;

Sheppard, Paul W. ;

Mayer, R. John ;

Roelofs, Jeroen .

TRENDS IN CELL BIOLOGY, 2010, 20 (07) :391-401

[8] Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases [J].

Bhattacharya, Seemana ;

Chakraborty, Dipankar ;

Basu, Malini ;

Ghosh, Mrinal K. .

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2018, 3

[9] Identification of the familial cylindromatosis tumour-suppressor gene [J].

Bignell, GR ;

Warren, W ;

Seal, S ;

Takahashi, M ;

Rapley, E ;

Barfoot, R ;

Green, H ;

Brown, C ;

Biggs, PJ ;

Lakhani, SR ;

Jones, C ;

Hansen, J ;

Blair, E ;

Hofmann, B ;

Siebert, R ;

Turner, G ;

Evans, DG ;

Schrander-Stumpel, C ;

Beemer, FA ;

van den Ouweland, A ;

Halley, D ;

Delpech, B ;

Cleveland, MG ;

Leigh, I ;

Leisti, J ;

Rasmussen, S ;

Wallace, MR ;

Fenske, C ;

Banerjee, P ;

Oiso, N ;

Chaggar, R ;

Merrett, S ;

Leonard, N ;

Huber, M ;

Hohl, D ;

Chapman, P ;

Burn, J ;

Swift, S ;

Smith, A ;

Ashworth, A ;

Stratton, MR .

NATURE GENETICS, 2000, 25 (02) :160-165

[10] Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination [J].

Braten, Ori ;

Livneh, Ido ;

Ziv, Tamar ;

Admon, Arie ;

Kehat, Izhak ;

Caspi, Lilac H. ;

Gonen, Hedva ;

Bercovich, Beatrice ;

Godzik, Adam ;

Jahandideh, Samad ;

Jaroszewski, Lukasz ;

Sommer, Thomas ;

Kwon, Yong Tae ;

Guharoy, Mainak ;

Tompa, Peter ;

Ciechanover, Aaron .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (32) :E4639-E4647

← 1 2 3 4 5 6 7 8 9 10 →